Brief: Onxeo acquires DNA Therapeutics

Valerio Therapeutics SA

29/02/2016 17:40

Feb 29(Reuters) - Onxeo SA  C4X.PA : 
    * Buys DNA Therapeutics for upfront payment of 1.7 million 
euro ($1.85 million) in common shares at deal closing 
    * Additional payment will come in the form of milestones 
    * Large part of dna therapeutics' historical shareholders to 
invest 1 million euro in cash in Onxeo shares 
    * Says phase 3 clinical trials of Validive are more costly 
than expected; To seek for a partner 
 
     
     
 Source text for Eikon:  urn:newsml:reuters.com:*:nBw2zgvkwa 
     
 Further company coverage:  C4X.PA   
    
 
 
 
($1 = 0.9199 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))